Pharma

Your Article Summary

See Latest Articles

Onglyza (saxagliptin), a new treatment for type 2 diabetes mellitus in adults, now available in u.s. pharmacies
AstraZeneca, 08/17/09

Bristol–Myers Squibb Company and AstraZeneca announced that ONGLYZA, a dipeptidyl peptidase–4 inhibitor, approved by the U.S. Food and Drug Administration on July 2009, is now available, by prescription, in pharmacies across the United States. Bristol–Myers Squibb and AstraZeneca began shipping ONGLYZA to wholesalers the next business day following the FDA approval.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals